These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19995982)

  • 1. Mutation patterns in cancer genomes.
    Rubin AF; Green P
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21766-70. PubMed ID: 19995982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population sequencing data reveal a compendium of mutational processes in the human germ line.
    Seplyarskiy VB; Soldatov RA; Koch E; McGinty RJ; Goldmann JM; Hernandez RD; Barnes K; Correa A; Burchard EG; Ellinor PT; McGarvey ST; Mitchell BD; Vasan RS; Redline S; Silverman E; Weiss ST; Arnett DK; Blangero J; Boerwinkle E; He J; Montgomery C; Rao DC; Rotter JI; Taylor KD; Brody JA; Chen YI; de Las Fuentes L; Hwu CM; Rich SS; Manichaikul AW; Mychaleckyj JC; Palmer ND; Smith JA; Kardia SLR; Peyser PA; Bielak LF; O'Connor TD; Emery LS; ; ; Gilissen C; Wong WSW; Kharchenko PV; Sunyaev S
    Science; 2021 Aug; 373(6558):1030-1035. PubMed ID: 34385354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics portrait of ductal carcinoma in situ in young women.
    Hong R; Cao B; Chen D; Wu W; Luo T; Lv D; Zhang W; Wang S; Shao K
    Breast Cancer Res Treat; 2024 Jul; 206(1):105-118. PubMed ID: 38704773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
    Pandya PH; Jannu AJ; Bijangi-Vishehsaraei K; Dobrota E; Bailey BJ; Barghi F; Shannon HE; Riyahi N; Damayanti NP; Young C; Malko R; Justice R; Albright E; Sandusky GE; Wurtz LD; Collier CD; Marshall MS; Gallagher RI; Wulfkuhle JD; Petricoin EF; Coy K; Trowbridge M; Sinn AL; Renbarger JL; Ferguson MJ; Huang K; Zhang J; Saadatzadeh MR; Pollok KE
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex mutation profiles in mismatch repair and ribonucleotide reductase mutants reveal novel repair substrate specificity of MutS homolog (MSH) complexes.
    Lamb NA; Bard JE; Loll-Krippleber R; Brown GW; Surtees JA
    Genetics; 2022 Jul; 221(4):. PubMed ID: 35686905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes.
    Al-Farsi H; Al-Azwani I; Malek JA; Chouchane L; Rafii A; Halabi NM
    J Transl Med; 2022 May; 20(1):244. PubMed ID: 35619151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures.
    Abbasi A; Alexandrov LB
    DNA Repair (Amst); 2021 Nov; 107():103200. PubMed ID: 34411908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.
    Banerjee S; Raman K; Ravindran B
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries.
    Carbonnier V; Leroy B; Rosenberg S; Soussi T
    Sci Rep; 2020 Nov; 10(1):20368. PubMed ID: 33230179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data.
    Wang LJ; Zhang CW; Su SC; Chen HH; Chiu YC; Lai Z; Bouamar H; Ramirez AG; Cigarroa FG; Sun LZ; Chen Y
    BMC Genomics; 2019 Dec; 20(Suppl 12):1007. PubMed ID: 31888480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signatures of replication timing, recombination, and sex in the spectrum of rare variants on the human X chromosome and autosomes.
    Agarwal I; Przeworski M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17916-17924. PubMed ID: 31427530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference.
    Matsutani T; Ueno Y; Fukunaga T; Hamada M
    Bioinformatics; 2019 Nov; 35(22):4543-4552. PubMed ID: 30993319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation Alters the Properties of Pol η: Implications for Translesion Synthesis.
    Peddu C; Zhang S; Zhao H; Wong A; Lee EYC; Lee MYWT; Zhang Z
    iScience; 2018 Aug; 6():52-67. PubMed ID: 30240625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling.
    Pantsar T; Rissanen S; Dauch D; Laitinen T; Vattulainen I; Poso A
    PLoS Comput Biol; 2018 Sep; 14(9):e1006458. PubMed ID: 30199525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
    Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
    BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approaches for discovery of mutational signatures in cancer.
    Baez-Ortega A; Gori K
    Brief Bioinform; 2019 Jan; 20(1):77-88. PubMed ID: 28968631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting Determinants of Mutation Rates in Germline and Soma.
    Chen C; Qi H; Shen Y; Pickrell J; Przeworski M
    Genetics; 2017 Sep; 207(1):255-267. PubMed ID: 28733365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations.
    Balendran S; Liebmann-Reindl S; Berghoff AS; Reischer T; Popitsch N; Geier CB; Kenner L; Birner P; Streubel B; Preusser M
    J Neurooncol; 2017 Jul; 133(3):469-476. PubMed ID: 28497333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.